Protalix BioTherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $78.7M
Liabilities Breakdown FY2012
Total Liabilities: $82.1M
Asset Breakdown
Total Assets: $78.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $52.0M | 66.1% |
| Accounts Receivable | $1.4M | 1.8% |
| Inventory | $4.0M | 5.1% |
| Property, Plant & Equipment | $16.3M | 20.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $4.9M | 6.3% |
Liabilities Breakdown
Total Liabilities: $82.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.3M | 6.4% |
| Long-Term Debt | $5.4M | 6.6% |
| Other Liabilities | $71.4M | 87.0% |